CXCR2 and melanoma: In a xenograft mouse model of human melanoma, we recently showed that ACT of CXCR2 engineered T cells double the frequency of human CD3+ T cells in s.c. human melanomas, which is substantiated by the identification of CD3+ T cells infiltrating deep into the tumors by IHC [3].